MARTHA PENA: Open Payments
NPI 1104133594 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$781 in 16 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $417 · 2025 $781
Food & beverage: $781
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 2 | $169 |
| Abbott Laboratories | 1 | $157 |
| GENZYME CORPORATION | 1 | $140 |
| Novo Nordisk Inc | 1 | $116 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Amgen Inc. | 4 | $79 |
| Lilly USA, LLC | 1 | $17 |
| PFIZER INC. | 1 | $14 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, DEXCOM G7 GSS (161), KEVZARA, Ozempic, BREZTRI, REPATHA, Dexcom G6 Transmitter, MOUNJARO.
Industry payments across FL — which companies pay providers there.
